MicroRNA-377-3p inhibits growth and invasion through sponging JAG1 in ovarian cancer

[1]  Lianjie Hou,et al.  MiR-199b represses porcine muscle satellite cells proliferation by targeting JAG1. , 2019, Gene.

[2]  Junrong Wang,et al.  MicroRNA-377 Targets Zinc Finger E-box-Binding Homeobox 2 to Inhibit Cell Proliferation and Invasion of Cervical Cancer. , 2019, Oncology research.

[3]  Chuanmei Xie,et al.  Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  K. Tewari,et al.  Targeted treatment of advanced ovarian cancer: spotlight on rucaparib , 2018, Therapeutics and clinical risk management.

[5]  M. Bellon,et al.  JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells , 2018, Journal of Hematology & Oncology.

[6]  Aichun Liu,et al.  miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1. , 2018, Pathology, research and practice.

[7]  Jinhui Liu,et al.  MicroRNA-665 suppresses the growth and migration of ovarian cancer cells by targeting HOXA10 , 2018, Molecular medicine reports.

[8]  J. Xu,et al.  Down-regulation of miR-377 contributes to cisplatin resistance by targeting XIAP in osteosarcoma. , 2018, European review for medical and pharmacological sciences.

[9]  D. Dai,et al.  Expression of miR‐634 in gastric carcinoma and its effects on proliferation, migration, and invasion of gastric cancer cells , 2018, Cancer Medicine.

[10]  L. Chen,et al.  MiR-377 suppresses cell proliferation and metastasis in gastric cancer via repressing the expression of VEGFA. , 2017, European review for medical and pharmacological sciences.

[11]  M. Khullar,et al.  Downregulation of miR-377 Promotes Oral Squamous Cell Carcinoma Growth and Migration by Targeting HDAC9 , 2017, Cancer investigation.

[12]  Lijun Ma,et al.  miR‐598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT , 2017, Experimental cell research.

[13]  L. Li,et al.  [Expression of Jagged1 mRNA in human epithelial ovarian carcinoma tissues and effect of RNA interference of Jagged1 on growth of xenograft in nude mice]. , 2016, Zhonghua fu chan ke za zhi.

[14]  Z. Xie,et al.  Expression level of microRNA-195 in the serum of patients with gastric cancer and its relationship with the clinicopathological staging of the cancer. , 2016, European review for medical and pharmacological sciences.

[15]  Hsuan-Yu Chen,et al.  JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer , 2016, PloS one.

[16]  Henry C Kitchener,et al.  Ovarian cancer , 2014, The Lancet.

[17]  Wen-chang Lin,et al.  Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers , 2014, Expert Reviews in Molecular Medicine.

[18]  E. Lengyel.  Ovarian cancer development and metastasis. , 2010, The American journal of pathology.

[19]  Tian-Li Wang,et al.  Jagged1 Expression Regulated by Notch3 and Wnt/β-catenin Signaling Pathways in Ovarian Cancer , 2010, Oncotarget.

[20]  I. Shih,et al.  Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion. , 2008, Cancer research.

[21]  Artemis G. Hatzigeorgiou,et al.  Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer , 2008, Proceedings of the National Academy of Sciences.

[22]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[23]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[24]  Hys Ngan,et al.  Carcinoma of the Ovary , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[25]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[26]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[27]  P Maisonneuve,et al.  Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.